Leadership Team
Meet our experienced team.
Attending from Abzena will be; Gildas Lavenant, Vice President of Business Development, Roger Bowie, Vice President of Business Development, Dr. Thomas Cornell, Senior Manager, Protein Engineering, and Johanna Midelet, Senior Manager, Chemistry.
Our experts will be on hand to discuss how, as a highly specialized, leading complex biologics CDMO, we have the experience to accelerate your path to the clinic or commercialization for mammalian, microbial, and bioconjugate modalities.
Unlocking the Bispecific Mystery: Mastering the art of developing a successful Bispecific Antibody
Expanding therapeutics from a single functional antibody to a sophisticated bispecific bifunctional design can present unique challenges. Abzena’s developed a unique screening strategy that uses avidity, spacing and formatting of Fab and scFv arms to overcome any complexities that these molecules may present. Our approach focuses on key bispecific formats to provide a diverse portfolio of molecules within the smallest number of constructs. By leveraging unparalleled expertise in antibody production, purification, and functional bioassays, we rapidly identify and advance the most promising bispecific candidates.
Speaker: Dr Thomas Cornell, Protein Engineering Senior Manager, Abzena
We look forwad to connecting with you at the Festival of Biologics in Basel, CA.